EPCAM and hepatocellular carcinoma: Because we previously showed that there was no association between the expression of ALDH1 and EpCAM or CD13 and that ALDH1-knockdown affected neither cell growth nor tumorigenicity in HCC cells [13], we conducted loss-of-function assays on ALDH2.